生物疗法和心脏代谢风险在牛皮:一个回顾性审查
Annika Smith1,2,3, Aidin Karahasan4,5, Deborah Yi4,5
1Department of Dermatology, Westmead Hospital, Sydney, NSW, Australia. Asmi3525@uni.sydney.edu.au.
Dermatology and therapy
|January 22, 2025
概括
生物治疗显著改善了牛皮的皮肤严重程度,但在一年后没有改善心脏代谢风险标志物,如脂质样本或HbA1c. 需要进一步的研究来了解牛皮患者对心血管健康的长期影响.
科学领域:
- 皮肤病学 皮肤病学
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
背景情况:
- 牛皮是一种系统性炎症性疾病,与心脏代谢风险增加有关,包括失脂症和糖尿病.
- 生物疗法是有效的管理牛皮的皮肤炎症,并可能减少导致心血管风险的系统性炎症.
研究的目的:
- 为了评估心脏代谢风险标志物的变化,在接受一年连续生物治疗的牛皮患者.
主要方法:
- 对39名慢性斑块性牛皮患者进行了回顾性审查,这些患者接受了生物制剂治疗.
- 评估牛皮区域和严重性指数 (PASI) 皮肤改善.
- 在基线和12个月内监测脂质样本 (TC,LDL,HDL,TG) 和HbA1c.
主要成果:
- 帕西分数显著降低 (p < 0.001),表明皮肤严重程度有所改善.
- 在12个月后,没有观察到脂质谱 (TC,LDL,HDL,TG) 的显著变化.
- 没有检测到HbA1c水平的显著变化.
结论:
- 一年治疗牛皮的生物疗法并没有显著改善心脏代谢风险标志物.
- 需要对更大的队列进行进一步的研究,以澄清牛皮患者生物治疗的心脏代谢益处.
- 优化对这一患者群体的护理需要对生物治疗对心血管健康的影响有更深入的了解.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
115
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
115
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
Inflammatory Bowel Disease IV: Pharmacological Management
109
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
109
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
Genome-wide Association Studies-GWAS
12.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.4K


